Tezcan Gönül KELEŞ, Zeki KAYGISIZ, Özlem TÜNGER, Melek SAKARYA

Sezaryen operasyonu sonrası citrobacter freundii bakteriyemisine eşlik eden ciddi trombositopeni (olgu sunumu)

Peripartum bakteriyemi, preterm gebelikler ve sezaryen operasyonları ile ilişkilidir. Sitrobakterler, gram-negatif basillerdir ve fırsatçı enfeksiyonlara neden olurlar. Sitrobakter bakteriyemişine bağlı mortalite oranı % 48 dir. Erken tanı ve doğru tedavi komplikasyonları azaltabilir. Bu olguda, 29 yaşında, 34 haftalık bir gebede sezaryen operasyonu sonrası postoperatif 1 .günde trombosit sayısının 15.000 mL'"ye kadar düşmesine yol açan immun trombositopeni ve Citrobacter freundii bakteriy emişi ile bunlara bağlı klinik tabloyu, olası etyolojik nedenleri tartışarak sunmayı amaçladık.

Anahtar Kelimeler:

Trombositopeni, Sezaryen, Bakteriyemi, Citrobacter freundii, Bakteriyel translokasyon

Severe thrombocytopenia accompaning citrobacter freundii bacteremia following cesarean section (case report)

Peripartum bacteremia is associated with preterm pregnancies and cesarean sections. Citrobacter are gram-negative bacilli that can cause opportunistic infections. Overall mortality of Citrobacter bacteremia is seen in 48 %. Early diagnosis and prompt treatment can lessen complications. In the present case, (with Citrobacter freundii bacteriemia and immun thrombocytopenia) 29 years old, 34 weeks pregnant woman who had got platelet counts decreased 15.000 mL1 at postoperative first day following cesarean section, and related clinical conditions and probable etiologic factors are presented.

Keywords:

Thrombocytopenia, Cesarean Section, Bacteremia, Citrobacter freundii, Bacterial Translocation,

PDF

___

1. Gebre-Selassie S. Asymptomatic bacteriuria in pregnancy: epideiological, clinical and microbiological approach. Ethiop Med J. 1998 ; 36: 185-92.
2. Drelichman V, Band JD. Bacteriemias due to Ctrobacter diversus and Citrobacter freundii. Incidence, risk factors, and clinical outcome. Arch Intern Med. 1985; 145: 1808-10.
3. Manganello S, Tayara A, Perazzi B, et al. Characterization and distribution of Citrobacter species in a university hospital (abstract). Enferm İnfecc Microbiol Clin 2001; 19 (1): 11-4.
4. Sedman PC, MacFie S, Sağar P, et al. The prevalance of gut transocation in humans. Gastroenterology 1994; 107: 643-9.
5. O' Boyle CS, MacFie J, Mitchell CJ, et al. Microbiology of bacterial translocation in humans. Gut 1998; 42: 29-35.
6. Woodcock NP, Robertson J, Morgan DR, et al. Bacterial translocation and immunohistochemical measurement of gut immune function. J Clin Pathol 2001; 54: 619-23.
7. Kim BN, Woo Jh, Ryu J, Kim YS. Resistance to extended-spectrum cephalosporins and mortality in patients with Citrobacter freundii bacteremia. Infection 2003; 31: 202-7.
8. Crawford GE. An approach to use of antimicrobial agents. In: Civetta JM, Taylo RW, Kirby RR (eds). Critical care. 2 nd edition. Philadelphia: Lippincott company; 1992, 955-70.
9. Sanlı S, Kayacan N, Yeğin A ve ark. HELLP sendromu ve spinal anestezi. Türk Anest Rean Der Dergisi 2003; 31: 422-5.
10. Simmons E. Bleeding and Hemostatis. In Bongard FS, Sue DY (eds). Critical care diagnosis and treatment. 1 st edition. Connecticut :Appleton-Lange; 1994,199-213.
11. Bussel JB. Intravenous immunoglobulin therapy for the treatment of idiopathic thrombocytopenic purpura. Prog Hemost Thromb. 1986; 8: 103-25.
12. Kimura S, Kuroda J, Akaogi T et all. Treatment of steroid-resistant idiopathic thrombocytopenic purpura in pregnancy with repeated hig-dose intravenous immunoglobulin. Haematologia 2001 ;31:262-5.